Abilify Lawsuit Dismissed


LAW360 reports that a Pennsylvania federal judge has dismissed a lawsuit over a movement disorder attributed to Bristol-Myers’ drug Abilify.  The judge held that drug makers are not required to provide detailed instructions to physicians about monitoring adverse reactions.

Article →

Previous articleGovernments Delivering Customers to Big Pharma
Next articlePA Court Affirms Dismissal of Paxil Wrongful Death Suit
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].